China’s Top Leaders Reiterate Support for Covid Zero: CCTV
(Bloomberg) -- China's top leaders warned against questioning Xi Jinping's Covid Zero strategy, as pressure builds to relax virus curbs and protect the economic growth that has long been a source of Communist Party strength.
The Politburo's supreme Standing Committee pledged Thursday during a meeting led by Xi to “fight against any speech that distorts, questions or rejects our country's Covid-control policy,” state broadcaster China Central Television said. The body reaffirmed its support for the lockdown-dependent approach, saying China had made progress toward overcoming its worst outbreak since the first wave in Wuhan two years ago.
“Our pandemic prevention-and-control strategy is determined by the party's nature and principles,” the seven-member committee said, according to CCTV. “Our policy can stand the test of history, and our measures are scientific and effective.”
The Standing Committee's comments follow remarks from White House medical adviser Anthony Fauci who said China's virus lockdowns were unlikely to be successful in the long term. The nation's economic activity contracted sharply in April as restrictions to contain outbreaks closed factories and snarled supply chains.
China is facing sustained criticism and public discontent over its lockdowns. While new cases in Shanghai fell slightly to 4,651 on Wednesday, infections in Beijing held steady at 50.
| More on China's Covid crisis: |
|---|
The outbreaks are forcing the party to choose between the economic growth that has provided a source of legitimacy for more than four decades and Xi's efforts to show China's model is superior to Western democracy. Xi can afford little internal dissent as he prepares for a twice-a-decade leadership reshuffle leader this year, when he's expected to secure a precedent-breaking third term.
Senior health officials made similar remarks about the Covid Zero strategy last week. They said it gives China time to boost vaccination rates among the elderly and other vulnerable groups, increase hospital capacity and develop and produce more antivirals before declaring victory over Covid-19.
China has a large elderly population with insufficient overall medical resources, as well as imbalances in regional development, the Politburo Standing Committee said. Relaxing Covid controls would lead to large-scale infections, a surge in serious cases and deaths, damaging the economy and people's health, it said.
“Persistence is victory,” the body said. “Right now, Covid-control work is at a critical stage where we will retreat if we don't keep going, like we are rowing a boat upstream.”
©2022 Bloomberg L.P.
With assistance from Bloomberg
-
Signature Play: The Classic Cocktail Is Dead. Or Is It?
Classic cocktails are disappearing from India's cocktail menus. But they're still being ordered, taught to bartenders and borrowed from. So, who's really having the last drink?
-
A New Samvat Wishlist: Inclusive Prosperity And Human Development
India has strengthened its economic foundations through infrastructure, digital access and enterprise. Its next growth chapter must deepen productivity, create better livelihoods and widen participation in prosperity.
-
Love, Sex Aur Dhokha: The Audacious Plot To Spy On Jensen Huang
A Taipei dinner, a Singapore chip buyer and a suspected Chinese asset: inside the alleged spy operation that got close to NVIDIA's Jensen Huang.
-
Ten Things I Learnt This Samvat
Patience can be a trap. Cheap stocks can stay cheap. Leverage can wipe you out. What did Samvat 2082 teach us? Niraj Shah writes on 10 lessons from the year gone by.
-
Talking Points This Week: Tech Nerves, FII Buying, And A Faraway Banking Shock
The global markets are not shining this Diwali. The exception in the large markets is, India.
-
Midterm Rally Lasted A Day. The Hard Reality Of A Divided US May Last Two Years | Opinion
Between a contested AI boom, a debt ceiling that arrives in 2027 and a president with every incentive to act alone, the next two years may prove more volatile than the first day's rally suggests.
-
Blue Wave Will Derail the AI Trade but Won't Dismantle the AI Era | Unhedged Position
The Democrats' sweep of the US Congress will see politics collide with economic forces both over the long and short term.
-
It's Time To Take The GST Council's Bet On Trust Global
Payment records can prove India's services exports, and clear, proportionate rules can bring foreign digital sellers into the tax net.
-
Opinion | India at 38: From Innovation Overperformer to Innovation Powerhouse
India now has 453 VC-backed deep science startups, 18 of them late-stage, after 117 percent growth since 2020. Laurus Labs, at USD 9.3 billion, is the most valuable deep science company in any middle-income economy outside China.